In contrast, in our study, both Nf‐H Abs and Nf‐L ICs in blood appear to increase longitudinally in all symptomatic C9+ve ALS patients, individuals with an intermediate rate of disease progression compared to faster and slower ALS patients. The gene discussed is NEFH; the disease is amyotrophic lateral sclerosis.